Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Summary of the MSEK 43.4 share right issue

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, WITHIN OR INTO THE AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL The final result in the share right issue in TargetEveryone AB (“the Company”), for which the subscription period ended on Jun 10, 2019, shows that 3,549,812 shares, corresponding to approximately 3.3 per cent of the shares offered, were subscribed for by the exercise of subscription rights. In

Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors

LUND, SWEDEN - June 14, 2019 - Immunophotonics, Inc. and Clinical Laserthermia Systems, AB (CLS) today announced they have entered into a research collaboration agreement to support a Phase 1b/2a clinical trial for cancer patients with certain solid tumor indications. The research will utilize each company’s respective products and methodologies during treatments and is intended to support early phase clinical trials facilitated by a leading clinical organization.  Eligible patients with solid tumors will be treated using the locally administered CLS Immunostimulating Interstitial Laser

Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors

ST. LOUIS and IRVINE, CA - June 14, 2019 - Immunophotonics, Inc. and Clinical Laserthermia Systems, AB (CLS) today announced they have entered into a research collaboration agreement to support a Phase 1b/2a clinical trial for cancer patients with certain solid tumor indications. The research will utilize each company’s respective products and methodologies during treatments and is intended to support early phase clinical trials facilitated by a leading clinical organization.  Eligible patients with solid tumors will be treated using the locally administered CLS Immunostimulating

Outotec launches cost-effective FP-S filter press for standard filtration applications

For standard filtration applications, when a short delivery lead-time and safe, reliable operation are top of the priority list, the new Outotec FP-S filter press fits the bill perfectly. It offers efficient solid-liquid separation, is available in a wide range of configurations, and is backed by Outotec's expert technical services to ensure reliable process performance and long equipment lifetime. To extend the scope of filter press offerings to customers, Outotec has launched the FP-S filter press, which features a standard design and options for short lead times and reduced capital

Nokian Tyres plc lowers its guidance for 2019

Nokian Tyres plc Insider information June 14, 2019, 1:55 p.m. Due to the weakened car demand and continuously soft car tire market especially in Central Europe, Nokian Tyres plc lowers its earlier guidance for the full year 2019. The company expects short-term weakness in sales volume growth in Central Europe to continue during the remainder of the year. Updated guidance for 2019: In 2019, net sales with comparable currencies are expected to be slightly higher and operating profit to be lower compared to 2018. In line with Nokian Tyres’ updated 2018 strategy, the company is

SyntheticMR receives FDA clearance for use of SyMRI® on MRI systems from Siemens Healthineers

The new regulatory clearance from the American Food and Drug Administration, FDA, relates to the company's product package SyMRI IMAGE and SyMRI NEURO. The clearance means that SyMRI is now also supported for clinical use together with MRI systems from Siemens.SyMRI IMAGE is designed to optimize workflow and shorten the exam time using synthetic MRI, where up to 8 different contrast images are obtained through an exam of about 6 minutes. SyMRI NEURO is the next level of quantitative MR. The unique technology measures the absolute tissue properties of the brain and provides quantitative

BerGenBio presents preliminary Phase II clinical data at EHA 24: bemcentinib in combination with low dose chemotherapy yields durable responses in AML patients unfit for intensive chemotherapy

· Two posters to be presented at the 2019 annual congress of the European Hematology Association on 14th June · Phase II trial evaluating bemcentinib in combination with low-intensity chemotherapy in elderly acute myeloid leukaemia (AML) patients unfit for intensive chemotherapy shows significant efficacy · Preliminary responses reported in 6/14 (43%) patients, with CR/CRi in 4/14 (29%) patients; this is substantially higher than previously observed/historical benchmarks in single-agent cytarabine (low-dose chemotherapy) · Median relapse-free survival 7.9 months in CR/CRi patients (

Change in the holding of Kesko Corporation's treasury shares

A total of 2,480 Kesko B shares (KESKOB) have been returned to Kesko Corporation without consideration in accordance with the terms and conditions of Kesko's share-based compensation plan 2014-2016, the 2017 Performance Share Plan (PSP), and the transitional 2017-2020 Bridge Plan. The shares had initially been transferred to persons included in the target groups of the 2016 and 2017 performance periods of the share-based compensation plans.After the return of the shares, Kesko holds 930,444 of its own B shares as treasury shares. Further information is available from Mika Majoinen, EVP,

Saab’s Gripen offer to Finland includes GlobalEye

Saab announces that its Gripen offer to Finland, submitted in January this year, also includes two GlobalEye Airborne Early Warning and Control (AEW&C) aircraft.GlobalEye is a strategic asset, which can be in operation 24/7 for airspace and ground surveillance. Such AEW&C capability would increase Finland’s situational awareness and provide increased pre-warning time, supporting the protection of the nation’s territorial integrity. AEW&C systems have shown to provide an efficient deterrent effect whilst enhancing and maximizing the combat effectiveness of a fighter fleet. “Our offer to

ExpreS2ion co-author of article demonstrating that human antibodies from RH5 vaccine block binding to blood cells

ExpreS2ion Biotech Holding AB (“ExpreS2ion”) announces that a scientific article, documenting that human antibodies against the RH5 protein can stop the malaria parasite from entering human blood cells, has been published in the highly renowned journal Cell. The article is based on a clinical study conducted by researchers at the University of Oxford together with a consortium of research entities including ExpreS2ion.The clinical study was a part of a clinical trial in Oxford of the first vaccine that targets the RH5 malaria protein in a phase I/IIa study. The study was led by researchers

Balder acquires a property portfolio in Gothenburg for SEK 800 million

Fastighets AB Balder (publ) has today taken possession of a property portfolio in Gothenburg consisting of hotels, offices, logistics and residentials for approximately SEK 800 million. The lettable area amounts to approximately 55,000 sqm and rental income to approximately SEK 60 million. For further information, please contactCEO Erik Selin, tel. +46 706 074 790 orHead of Finance Marcus Hansson, tel. +46 768 369 848 Fastighets AB Balder is a listed real estate company which shall meet the needs of different customer groups for premises and housing through local support. Balder's

Kids go free with Stena Line

Stena Line helps families save money on trips to Ireland SUMMER is here and what better way to celebrate than to plan a value packed trip away and make lasting memories with the whole family. Leading ferry company Stena Line has launched Kids Go Free* which offers families the opportunity to save on trips across the Irish Sea via the Holyhead - Dublin, Fishguard – Rosslare, Cairnryan – Belfast, Liverpool – Belfast routes. Kids Go Free, which allows children up to 15 years of age to travel free, can be booked online now on all Stena Line sailings. So, if it is a spontaneous summer

Kids go free with Stena Line

SUMMER is here and what better way to celebrate than to plan a value packed trip away and make lasting memories with the whole family. Leading ferry company Stena Line has launched Kids Go Free* which offers families the opportunity to save on trips across the Irish Sea via the Cairnryan – Belfast, Liverpool – Belfast, Holyhead – Dublin and Fishguard – Rosslare routes. Kids Go Free, which allows children up to 15 years of age to travel free, can be booked online now on all Stena Line sailings. So, if it is a spontaneous summer holiday, wacky weekend trip in autumn or wonderful winter

Kids go free with Stena Line

Stena Line helps families save money on trips to Great Britain SUMMER is here and what better way to celebrate than to plan a value packed trip away and make lasting memories with the whole family. Leading ferry company Stena Line has launched Kids Go Free* which offers families the opportunity to save on trips across the Irish Sea via the Dublin – Holyhead, Rosslare - Fishguard routes, Belfast to Cairnryan and Belfast – Liverpool routes. Kids Go Free, which allows children up to 15 years of age to travel free, can be booked online now on all Stena Line sailings. So, if it is a

Kids go free with Stena Line

SUMMER is here and what better way to celebrate than to plan a value packed trip away and make lasting memories with the whole family. Leading ferry company Stena Line has launched Kids Go Free* which offers families the opportunity to save on trips across the Irish Sea via the Belfast - Cairnryan, Belfast - Liverpool, Dublin - Holyhead and Rosslare – Fishguard routes. Kids Go Free, which allows children up to 15 years of age to travel free, can be booked online now on all Stena Line sailings. So, if it is a spontaneous summer holiday, wacky weekend trip in autumn or wonderful winter

VTT created a mini cupcake factory that can prepare personalised cupcakes in less than 2 minutes

Press release 14 June, 2019 Consumers demand more personalised and healthy foods. This trend combined with hectic lifestyle and snacking requires new on-site technologies to satisfy consumers’ needs. VTT created a prototype of a mini cupcake factory, which enables on-site production of personalised, healthy snacks in order to show that instant food production with tailored recipes is possible today. VTT’s cupcake machine produces on-demand single serving fresh, warm cakes starting from scratch in a matter of minutes. The user can choose a sweet or savoury cake and personalise its

Scandic recruits new HR and Sustainability Director

Scandic has recruited Bitte Ferngren as its new HR and Sustainability Director and member of its Executive Committee. Bitte will join Scandic in the fall of 2019 from her previous position as the HR Director of the international insurance company RSA Scandinavia.In the last 20 years, Bitte has held senior HR positions in several major organizations, including five years at Posten Sverige AB and nine years in the Telia Group. In the last four years, she was the HR Director of insurance company RSA Scandinavia, which includes the brands Trygg Hansa and Codan.“Bitte has solid experience from

Tethys Oil’s holding of own shares has exceeded 5 per cent

Tethys Oil AB (publ) (“Tethys Oil”) has, under the previously announced share repurchase program, on Tuesday 11 June 2019 repurchased 10,000 own shares. Following the acquisition, Tethys Oil’s holding of own shares amounts to 3,598,326 (including 1,644,163 redemption shares received under the split and redemption procedure resolved upon by the Annual General Meeting). The holding corresponds to 5.01 per cent of the total number of shares and votes in Tethys Oil. The total amount of shares in Tethys Oil, as of 31 May 2019, is 71,792,620, of which 35,896,310 are redemption shares.

Transitioning to ISO 45001 requires strong “culture change innovators”, says industry expert

Ahead of the Safety & Health Expo in London, Scottish Chamber of Safety Chair, Jane Murdoch, will ask peers to stand up and be counted during the transition to ISO 45001A leading health and safety expert is encouraging global practitioners to become “culture change innovators” to help organisations make the transition to the new ISO 45001 standard. Jane Murdoch, Chair of Scottish Chamber of Safety (SCoS), is encouraging peers to change mindsets around health and safety in their place of work. The term ‘culture’ appears for the first time in the new 45001 standard, launched in March

Raisio plc: Managers´ transactions

Raisio plc      Managers´ transactions 14 June 2019 MANAGERS’ TRANSACTIONS Person subject to the notification requirementName: Rannikko, ToniPosition: Chief Financial OfficerIssuer: Raisio OyjLEI: 74370083282NHIP4QD02 Notification type: INITIAL NOTIFICATIONReference number: 74370083282NHIP4QD02_20190614104753_2____________________________________________ Transaction date: 2019-06-13Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009002943Nature of the transaction: ACQUISITION(X) Executed under portfolio or asset management Transaction

James Nachtwey calls for peace with Memoria at Fotografiska Stockholm

Memoria James Nachtwey 14 June - 15 September Fotografiska Stockholm James Nachtwey, one of the world's most respected photojournalists, and considered the defining visual war reporter of his time, will be exhibiting a major retrospective, Memoria, at Fotografiska. The photographs in the exhibition are arranged in narrative sequences that include many of Nachtwey's most prominent bodies of work with almost 150 photographs and a film by Thomas Nordanstad.James Nachtwey was born in the state of New York and graduated from Dartmouth College, where he studied art history and political

NorgesCasino.com shifting focus to affiliate marketing

The website NorgesCasino.com  has been operating as a fully equipped online casino catered to Norwegian players since 2014, but the focus is shifting from hosting its own selection of casino games, to reviewing and recommending them instead. However, the target audience will remain the same; casino game fans in Norway. Compare and contrast The newly relaunched website features reviews and ratings of all the best Norwegian casinos Visitors can use the front page table to quickly compare casinos, or read a more in-depth review, complete with up-to-date

Actic Group recruits Sofia Brandberg as new CMO

Actic Group has recruited Sofia Brandberg as new Chief Marketing Officer. Sofia comes from a position as Marketing Director at Delicato, and has previously been Senior Brand Manager at Danone Nordic and management consultant at Bearing Point. Sofia will take up her new position in September 2019.“We are very pleased to be able to recruit Sofia Brandberg as new Chief Marketing Officer after a broad process. Her experience of leadership as well as driving business-oriented change in combination with data-driven marketing will be important factors in strengthening our customer relations and

ChromoGenics receives additional order from Vasakronan

Within less than a year, ChromoGenics has gain confidence by delivering window glasses to Vasakronan not less than three times. The latest project will also be installed in Uppsala, now at the property Kvarteret Duvan.The property was designed by architect Dag Ribbling and built in 1962. It is centrally located and close to Uppsala's pedestrian street and Central Station. Kvarteret Duvan which today mainly consists retail premises, will be rebuilt and replaced with office space. ChromoGenics is also helping out in the refurbishing of the window frames. This type of renovation requires high

There are no items matching the current filter
There are no more items matching the current filter
Back to top